Creative Biolabs rAb Blog

Menu

Skip to content
  • Therapeutic Antibody R&D
  • Recombinant Antibody R&D
  • Antibody Engineering R&D
  • News

Category Archives: News

Recombinant Antibody

Scientists Reviewed the Advances, Challenges and Countermeasures in Immunotherapy of Gastrointestinal Tumors

April 30, 2023Cancer Immunotherapy, NewsGastrointestinal Tumor, immunotherapybiorab

The morbidity and mortality of intestinal tumors are among the top malignant tumors, and they are major diseases that seriously threaten people’s health. The prognosis for some patients with gastrointestinal malignancies hasRead More…

Released! Mechanisms Behind Immune Cells’ Responses to Cancer Cell Mutations

March 12, 2023Cancer Immunotherapy, NewsCancer Immunotherapybiorab

Neoantigens are peptides derived from nonsynonymous mutations in human leukocyte antigens (HLAs) that are recognized by antitumor T cells. The large diversity of HLA alleles and limited clinical samples often narrow scientists’Read More…

Scientists Discovered the Key Molecule Triggering Cancer Metastasis

January 2, 2023Cancer Immunotherapy, NewsCancer Immunotherapybiorab

Many cancer cells never leave their original tumor tissue. Some cancer cells have evolved the ability to migrate to other tissues, but they will become dormant once they are unable to formRead More…

Transcriptional and Immunophenotypic Profiling Reveals Molecular and Immunological Features of Cancer Tumourigenesis

December 5, 2022Cancer Immunotherapy, NewsCancer Immunotherapybiorab

The paradigm of the adenoma-cancer sequence has typically focused on cancer cells in colorectal cancer (CRC) development that is already validated to entail heterologous interactions between altered cells and their surrounding microenvironment.Read More…

Astellas Claudin18.2 Antibody Phase III Clinical Trial—Primary Endpoint Reached!

November 18, 2022News, Therapeutic Antibody R&DClaudin18.2, Zolbetuximabbiorab

Astellas recently announced positive top-line results of the Phase III SPOTLIGHT clinical trial designed to evaluate the efficacy and safety of zolbetuximab in combination with mFOLFOX6—a combination regimen including oxaliplatin, calcium folinate,Read More…

Creative Biolabs Attended the 13th World Bispecific Summit as An Exhibition Partner

September 23, 2022NewsBispecific Antibody, World Bispecific Summitbiorab

As multispecifics is hailed the fourth wave of drug discovery, with more clinical candidates and commercial success than ever before, the 13th World Bispecific Summit arrived at a pivotal time to deliver the holyRead More…

Alternatives to Cope with Lengthy Clinical Development Process for COVID-19

April 5, 2020News, Recombinant Antibody R&DClinical Development, SARS-CoV-2, therapeutic antibodybiorab

The latest update— Cases of COVID-19 in the U.S. at a Glance on April 3, 2020, which include both confirmed and presumptive positive cases of COVID-19 reported to CDC or tested atRead More…

Cancer Res: The Causes of Chemotherapy Resistance in Breast Cancer

June 26, 2019NewsBreast Cancer, Chemotherapy Resistancebiorab

According to a study recently published in Cancer Research by researchers and colleagues at the Belvich Institute of Biomedicine at the University of Barcelona, a large number of replicated chromosome regions areRead More…

Scientists Found that Potassium Ions are the Key to Controlling the Anticancer Ability of T cells

April 17, 2019NewsCancer, Potassium Ion, T cellbiorab

A study led by scientists at the Center for Cancer Research (CCR) at the American National Cancer Institute (NCI) has revealed a way to promote the continued growth of tumors in theRead More…

3D Bio-printing Model Changes Anti-cancer Drug Development and Anti-tumor Therapy

February 19, 2019News3D Model, Bio-printing, Cancerbiorab

Researchers at the University of Minnesota have developed a way to study cancer cells, which could lead to new and more effective treatments. They have developed a new method to study theseRead More…

Posts navigation

  • 1
  • 2
  • 3
  • Next »

Categories

  • Antibody Engineering R&D
  • Cancer Immunotherapy
  • News
  • Recombinant Antibody R&D
  • Therapeutic Antibody R&D

Recent Posts

  • Scientists Reviewed the Advances, Challenges and Countermeasures in Immunotherapy of Gastrointestinal Tumors
  • Released! Mechanisms Behind Immune Cells’ Responses to Cancer Cell Mutations
  • The Ineffectiveness of Cancer Immunotherapy May Be Due to the Lack of Specific Key Immune Cells in Patients
  • Scientists Discovered the Key Molecule Triggering Cancer Metastasis
  • Transcriptional and Immunophenotypic Profiling Reveals Molecular and Immunological Features of Cancer Tumourigenesis

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs rAb Blog
Powered by WordPress , Designed and Developed by templatesnext